Cuifang Nie
Cuifang Nie has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Fei Yu
Hong Kong Quantum AI Lab
1 shared publication - Guangju Meng
Taian Cent Hosp, Dept Infect Dis, Tai An, Shandong, Peoples R China
1 shared publication Julin Shan
Shanghai Geyu Software Co. Ltd. Shanghai China
1 shared publication- Li Chen
Taian Cent Hosp, Dept Infect Dis, Tai An, Shandong, Peoples R China
1 shared publication - Li Liu
Taian Cent Hosp, Dept Infect Dis, Tai An, Shandong, Peoples R China
1 shared publication - Qin Sun
Taian Cent Hosp, Dept Infect Dis, Tai An, Shandong, Peoples R China
1 shared publication
Latest Publications
- Open Access
- 18 August 2021
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 30 (8) , 789-795
Expression of miR-9a-5p in cirrhosis patients with recurrent portal hypertension after treatment
Background. MicroRNA (miR) influences the biological activities of cirrhotic patients with recurrent portal hypertension. Objectives. The current study was designed to investigate risk factors related to the survival of cirrhosis patients and assessed the possibility of using miR-9a-5p predictability to prevent post-treatment portal hypertension. Materials and methods. Patients with portal hypertension due to liver cirrhosis treated from January 2015 to September 2016 were included in this study. Patients without relapse after treatment were selected as the success group while patients with relapse after treatment were selected as the recurrence group. Serum samples from healthy people were also collected. The blood indexes of the 2 groups of patients before and after treatment were compared and the miR-9a-5p serum level in each group was determined. The Kaplan-Meier method was applied to analyze three-year survival, Cox univariate regression was used to analyze the risk factors for recurrence of cirrhotic portal hypertension, and the receiver operating characteristic curve (ROC) was used to evaluate the diagnostic value of serum miR-9a-5p, total bilirubin (TBIL) and platelet (PLT) levels in patients with recurrence. Results. The miR-9a-5p level in the recurrence group was higher than that in the success group after treatment. In patients with recurrence, the miR-9a-5p level was negatively correlated with red blood cell count, TBIL, white blood cell count, and PLT count, and positively correlated with albumin. The miR-9a-5p, TBIL and PLT are potential markers of recurrent portal hypertension in liver cirrhosis. The miR-9a-5p had the highest area under the curve (AUC) value in patients with relapse. Conclusions. The miR-9a-5p is a risk factor for the recurrence of cirrhotic portal hypertension after treatment. It may be used as a marker of recurrence, and so has potential clinical value for the diagnosis and treatment of recurrent portal hypertension.
- 18 August 2021
- Published by Wroclaw Medical University in Advances in Clinical and Experimental Medicine
- Vol. 30 (8) , 789-795
Open AccessExpression of miR-9a-5p in cirrhosis patients with recurrent portal hypertension after treatment
Background. MicroRNA (miR) influences the biological activities of cirrhotic patients with recurrent portal hypertension. Objectives. The current study was designed to investigate risk factors related to the survival of cirrhosis patients and assessed the possibility of using miR-9a-5p predictability to prevent post-treatment portal hypertension. Materials and methods. Patients with portal hypertension due to liver cirrhosis treated from January 2015 to September 2016 were included in this study. Patients without relapse after treatment were selected as the success group while patients with relapse after treatment were selected as the recurrence group. Serum samples from healthy people were also collected. The blood indexes of the 2 groups of patients before and after treatment were compared and the miR-9a-5p serum level in each group was determined. The Kaplan-Meier method was applied to analyze three-year survival, Cox univariate regression was used to analyze the risk factors for recurrence of cirrhotic portal hypertension, and the receiver operating characteristic curve (ROC) was used to evaluate the diagnostic value of serum miR-9a-5p, total bilirubin (TBIL) and platelet (PLT) levels in patients with recurrence. Results. The miR-9a-5p level in the recurrence group was higher than that in the success group after treatment. In patients with recurrence, the miR-9a-5p level was negatively correlated with red blood cell count, TBIL, white blood cell count, and PLT count, and positively correlated with albumin. The miR-9a-5p, TBIL and PLT are potential markers of recurrent portal hypertension in liver cirrhosis. The miR-9a-5p had the highest area under the curve (AUC) value in patients with relapse. Conclusions. The miR-9a-5p is a risk factor for the recurrence of cirrhotic portal hypertension after treatment. It may be used as a marker of recurrence, and so has potential clinical value for the diagnosis and treatment of recurrent portal hypertension.
- 30 March 2021
- Published by Wiley in International Journal for Numerical Methods in Engineering
- Vol. 122 (15) , 3705-3732
PASM: Parallel aligned surface meshing
Computer‐aided design (CAD) models of industrial design are often plagued with a series of defects, including minute features, gaps, self‐intersections, and misalignments. The development of schemes in automatic defeaturing, gaps repairing, and intersection removal usually requires a discrete representation of the geometry. However, existing surface meshing methods could not effectively handle sliver surfaces and assemblies with complex contact conditions, including multiple misaligned curves/surfaces and degenerated or free‐form‐shaped interface of contact. A surface meshing method based on a meshing‐and‐synchronizing strategy is proposed, which tackles the mesh generation of sliver surfaces and the cleanup of misaligned assemblies by means of mesh alignment. The mesh generation is performed in a hierarchical manner with curves and surfaces being meshed in sequence. By incorporating the synchronization strategy into the curve/surface meshing process, curve/surface mesh alignment is achieved automatically without compromising the mesh quality. Thanks to the alignment, the curve mesh generated by aligned curve meshing (ACM) is free of intersections, which enhances the meshing of sliver surfaces. By enforcing mesh alignment, aligned surface meshing (ASM) can handle misaligned assemblies with complex contact conditions. ASM is parallelized by using OpenMP. Various assemblies characterized with difficult misaligned features and touches are well processed by parallel ASM.
- 30 March 2021
- Published by Wiley in International Journal for Numerical Methods in Engineering
- Vol. 122 (15) , 3705-3732
PASM: Parallel aligned surface meshing
Computer‐aided design (CAD) models of industrial design are often plagued with a series of defects, including minute features, gaps, self‐intersections, and misalignments. The development of schemes in automatic defeaturing, gaps repairing, and intersection removal usually requires a discrete representation of the geometry. However, existing surface meshing methods could not effectively handle sliver surfaces and assemblies with complex contact conditions, including multiple misaligned curves/surfaces and degenerated or free‐form‐shaped interface of contact. A surface meshing method based on a meshing‐and‐synchronizing strategy is proposed, which tackles the mesh generation of sliver surfaces and the cleanup of misaligned assemblies by means of mesh alignment. The mesh generation is performed in a hierarchical manner with curves and surfaces being meshed in sequence. By incorporating the synchronization strategy into the curve/surface meshing process, curve/surface mesh alignment is achieved automatically without compromising the mesh quality. Thanks to the alignment, the curve mesh generated by aligned curve meshing (ACM) is free of intersections, which enhances the meshing of sliver surfaces. By enforcing mesh alignment, aligned surface meshing (ASM) can handle misaligned assemblies with complex contact conditions. ASM is parallelized by using OpenMP. Various assemblies characterized with difficult misaligned features and touches are well processed by parallel ASM.